Impact of Widespread Introduction of Pneumococcal Conjugate Vaccines on Pneumococcal and Nonpneumococcal Otitis Media | Zendy

Shalom BenShimol | Zendy; Noga GivonLavi | Zendy; Eugene Leibovitz | Zendy; SIMON RAIZ | Zendy; David Greenberg | Zendy; Ron Dagan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of Widespread Introduction of Pneumococcal Conjugate Vaccines on Pneumococcal and Nonpneumococcal Otitis Media

Author(s) -

Shalom BenShimol,

Noga GivonLavi,

Eugene Leibovitz,

SIMON RAIZ,

David Greenberg,

Ron Dagan

Publication year - 2016

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciw347

Subject(s) - medicine , streptococcus pneumoniae , otitis , acute otitis media , pneumococcal infections , pneumococcal disease , pneumococcal conjugate vaccine , immunology , microbiology and biotechnology , antibiotics , surgery , biology

Pneumococcal conjugated vaccines (PCVs) impact on complex otitis media (OM; including recurrent, nonresponsive, and chronic OM with effusion) was greater than that on simple, acute OM in previous studies. Since complex OM is often a polymicrobial disease, we speculated that reduction of complex OM by PCVs would be associated with reduction of non-pneumococcal OM.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research